Skip to main content
. 2020 Nov 9;91(Suppl 13):e2020012. doi: 10.23750/abm.v91i13-S.10593

Table 1.

Genetic polymorphisms associated with sport performance

Gene Full name Associated phenotypes Polymorphism ID References
ACE Angiotensin I converting enzyme I allele, endurance performance; D allele, power performance rs4646994 (Alu I/D) 28,29,31,146
ACTN3 α-actinin-3 577Ter (T) allele, endurance performance; Arg577 (C) allele, power performance rs1815739 C>T 28,39,91,147
ADRB2 β-2adrenoreceptor 16Arg (A) and Gln27 (C) alleles, endurance performance rs1042713 G>A; rs1042714 C>G 92,93,94,146
BDKRB2 Bradykinin receptor B2 T allele, endurance performance rs1799722 C>T 93,146
COL5A1 Collagen, type V, α1 CC genotype, protection from exercise-associated muscle cramps during an ultra-marathon; T allele, endurance performance rs12722 C>T 95,96,146,148
CRP C-reactive protein, pentraxin-related A allele, endurance performance rs1205 A>G 97,98,146
GABPB1 GA binding protein transcription factor, β subunit 1 (nuclear respiratory factor 2 G allele, endurance performance rs7181866 A>G 99,146
PPARA Peroxisome proliferator-activated receptor α G allele, endurance performance; C allele, power performance rs4253778 G>C 100,101,146
PPARGC1A Peroxisome proliferator-activated receptor γ coactivator 1 α G allele, endurance performance rs8192678 G>A 102,103,146
VEGFA Vascular endothelial growth factor A C allele, endurance performance rs2010963 G>C 104,105,146
ADRA2A α-2A-adrenergic receptor Central role in the regulation of systemic sympathetic activity and hence cardiovascular responses such as heart rate and blood pressure Dra I identifies a restriction fragment length polymorphism in the 3_-untranslated region (6.7-/6.3-kb polymorphism 92
AMPD1 Adenosine monophosphate deaminase 1 GG homozygotes, elite power athlete status, quicker acceleration and sprint times rs17602729 G>A 77,149
EPAS1 Endothelial PAS domain protein 1 AA genotype in rs1867785, underrepresented in sprint/power athletes; TT genotype in rs11689011, underrepresented in sprint/power athletes rs1867785; rs11689011 124
NFATC4 Nuclear factor of activated T cell calcineurin-dependent 4 G allele, elite endurance athlete status rs2229309 G>C 125
NOS3 Nitric oxide synthase 3 GG genotype, slower than the other genotypes rs1799983 T>A>G 92,126
AGT Angiotensinogen 235Thr (C) allele, power performance rs699 T>C 106,107,146
IL6 Interleukin-6 G allele, power performance rs1800795 C>G 108,109,146
TRHR Thyrotropin- releasing hormone receptor C allele, muscle mass rs16892496 A>C 110,146
VDR Vitamin D receptor A allele, power performance rs1544410 A>G 111,112,146
PPARGC1B Peroxisome proliferator-activated receptor γ coactivator 1 α C allele, power athlete status rs10060424 T>A,C 114
PPARG Peroxisome proliferator-activated receptor γ G allele, short-term and very intense exertion with anaerobic energy production rs1801282 C>G 115
HIF1A Hypoxia-inducible factor 1α T allele, higher frequency in weightlifters and power-orientated athletes rs11549465 C>T 115,117,118
PTPRK Protein tyrosine phosphatase receptor type K C allele, sprint test performance rs55743914 C>T 120
TERT Telomerase reverse transcriptase G allele, sprinters rs33954691 G>A 120
RDH13 Retinol dehydrogenase 13 G allele, increased proportion of fast-twitch muscle fibres rs4806637 A>G 120
CBLN2 Cerebellin 2 precursor G allele, sprinters rs8093502 C>T 120
CPNE5 Copine V G allele, sprinters rs3213537 C>T 120
CNTN4 contactin 4 A allele, overrepresented in football players rs62247016 A>T 120
LINC00305, LINC01924 Long intergenic non-protein coding RNA 305, 1924 Functional role in development of atherosclerosis by inducing production of inflammatory cytokines in monocytes, by regulating apoptosis via miR-136 rs2850711 A>T 150
AGTR1 Angiotensin II receptor type 1 C allele, essential hypertension. A allele, downregulated by the miR-155 rs5186 A>C 151
MIR499A MicroRNA 499a GG genotype, myocardial infarction and ischemic stroke. The rs3746444 polymorphism disturbs regulation of blood pressure and anti-apoptotic effect in cardiomyocytes rs3746444 A>G 152
MIR4513 MicroRNA 4513 Blood pressure, total lipids, total cholesterol, low-density lipoprotein cholesterol, blood glucose. TT genotype, coronary artery disease. T allele, decrease in Mir-4513 rs2168518 C>T 152
MIR149 MicroRNA 149 Coronary artery disease rs2292832 T>C 152
MIR27A MicroRNA 27a C allele, increases in the expression of the miR with negative effect on adipogenesis. CC genotype, protective role against T2DM. G allele, increased risk of early cardiovascular autonomic neuropathy rs895819 T>A,C,G 152
CREB1 CAMP responsive element binding protein 1 A allele, smaller reduction in heart rate during a submaximal exercise test following training; greater exercise-induced temperature increase rs2253206 A>G,T 148
CPT2 Carnitine palmitoyltransferase 2 Minor alleles, CPT2 deficiency rs1799821 G>A; rs1799822 A>G 149
PYGM Muscle associated glycogen phosphorylase Truncating variant, exercise intolerance, cramps and contractures during exercise and stressful situations rs116987552 G>A 149
CNTF Ciliary neurotrophic factor GG genotype, athlete phenotype rs1800169 G>A 147
ACVR1B Activin A receptor type 1B Dynamic knee flexion and extension, isometric strength rs11612312 T>C; rs2854464 A>C,G 153
NGF Nerve growth factor CC genotype, more anxious females; TT genotype, more anxious males, less anxious females rs6330 C>T 154
BDNF Brain-derived neurotrophic factor CC genotype, quicker sprinters than A allele carriers rs6265 G>A 154
NGFR Nerve growth factor receptor Vagal autonomic dysregulation rs2072446 C>T 154
MSTN Myostatin Peak power during muscle contractions rs1805086 A>G 154,155
SCN9A Sodium voltage-gated channel alpha subunit 9 AA genotype, increased perception of pain rs1805086 A>G 154
COMT Catechol-O-methyltransferase A allele, higher dopamine levels; lower pain threshold; enhanced vulnerability to stress.
G allele, lower dopamine levels; higher pain threshold; better stress resiliency
s4680 G>A 154